EUCTR2009-012941-45-DK进行中（未招募）不适用
uRVO:Classification of Central Retinal Vein Occlusion and Management with Lucentis (Ranibizumab) - a randomised clinical trial. - LURVO
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1)Central veneokklusion i et eller begge øjne
- •2)Symptomvarighed = 3 måneder
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1)AMD forandringer værre end hårde drusen
- •2)Diabetiske øjenforandringer
- •3)Tidligere okulær kirurgi, bortset fra kataraktoperation
- •4)Enhver visus-ændrende kirurgi under selve studiet.
- •5)Anden væsentlig øjensygdom
- •6)Patienten ikke myndig eller ude af stand til at forstå den givne information.
- •7)Patienten kan ikke gennemføre kontrolprogrammet.
研究者
相似试验
已完成
4 期
Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVOCentral Retinal Vein OcclusionNCT02800642Bayer162
招募中
不适用
Treatment of retinal vein occulusioretinal vein occlusionJPRN-UMIN000000682Department of Ophthalmology,Yamagata University, School of Medicine30
Unknown
2 期
Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment.Central Retinal Vein Occlusion, Non-IschemicNCT02957760Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts30
已完成
4 期
Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein OcclusionVascular Occlusive DiseaseRetinal Vein OcclusionNCT06416241University of Athens51
已完成
1 期
Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein OcclusionCentral Retinal Vein OcclusionNCT01581411Weill Medical College of Cornell University1